Dr. Kristian Moller

Dr. Kristian Moller is a Principal Scientist at Atlas Antibodies. He holds a Ph.D. in Molecular Neurobiology from the Medical Faculty at Lund University Sweden. Kristian has a profound national and international R&D experience as a specialist in applied molecular histology from the private pharmaceutical, diagnostic and immunotherapy sectors. There his work has emphasized on research devoted to tumor diagnostic antibodies, T-cell mediated cancer immunotherapies and early drug discovery within dermatology. In addition to his general expertise in tissue biomarkers, he is strongly specialized in the technical aspects of immunohistochemistry and RNA in situ hybridization.

Recent Posts

Microglia: the brain’s immune barrier at the interface of good and bad

April 21, 2020

Microglia are brain-resident macrophages forming the first active immune barrier in the central nervous system. Microglia are endowed with a spectacular plasticity, allowing them to acquire multiple phenotypes and thereby fulfill their numerous functions in health and disease. In this blog post we share an overview of the existing knowledge regarding the neuro-modulatory function of microglia. 

Learn More

Topics:

Antibody Validation / Human Protein Atlas / Immunohistochemistry

Candidate Diagnostic Biomarkers for Lung Cancer

March 17, 2020

Available anti-lung cancer therapy treatments, like most other onco-therapies, also negatively affects the viability of healthy untransformed cells, causing unwanted side effects. The rapidly evolving and novel field of targeted anti-tumor therapies has become tailored to be more specific and more efficient in eradicating tumor cells and also radically reduce the damage to the normal parental tissue. Keep reading and learn more about the rapidly evolving field of targeted drug therapy in lung cancer.

Learn More

Topics:

Immunohistochemistry

Neuroscience research highlights from SfN 2019

November 19, 2019

The Annual Society for Neuroscience (SfN) meeting features the latest discoveries in brain research, from the basic mechanisms, to translational and clinical studies. Here are some highlights from the conference.

Learn More

How can I stain multiple proteins in the same tissue or cell?

June 25, 2019

As a rule, the complex biology and spatial organization of tissues and solid tumors poses a scientific and diagnostic challenge that is not sufficiently well addressed by standard immunohistochemistry (IHC) procedures. How come this is the case? The answer is that single IHC staining provides data on only one marker at a time. So, how do you stain multiple protein in the same cell or tissue?

Learn More

Topics:

Immunohistochemistry

Cancer research highlights from AACR 2019

May 14, 2019

Dr. Kristian Moller, Principal Scientist at Atlas Antibodies, shares the top research highlights from the exciting science being presented at AACR 2019.

Learn More

Tissue processing - how to succeed with your IHC part I

April 02, 2019

Would you print your childhood best and precious memories on a low-quality photographic film? I wouldn’t. However, just like me, you probably have hundreds of old faded yellow photos abandoned in a drawer. Images quality relies on high-quality printing films…and so does your immunohistochemical staining. Tissue handling and tissue processing determine the quality of your IHC results. You want high resolution?  Let’s understand how to achieve it.

Learn More

Topics:

Immunohistochemistry

Control your IHC: primary antibody controls you should know

February 19, 2019

How many decisions do you think you make every day? Would you be surprised if I tell you that an adult person makes about 25,000 more or less conscious decisions every day? It’s a fact. Consciously or unconsciously, we spend every day of our lives making decisions: where to go, what to wear, what to eat, how to spend our time, etc. But how much time do you spend making a decision for the right control for your primary antibody? And, most importantly, did you make the right choice? How can you tell a good decision from a bad one?

Learn More

Topics:

Immunohistochemistry

1

Share this article

Sign Up

Share this blog